CHLOE ASAKER: Open Payments
NPI 1336858752 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 41 payments from 22 companies in 2025. Trend: 2023 $1,344 · 2024 $1,118 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| PFIZER INC. | 4 | $115 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $59 |
| Exact Sciences Corporation | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $37 |
| Verona Pharma, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: REXULTI, AIRSUPRA, JARDIANCE, ELIQUIS, The Cologuard Plus Collection Kit, CAPLYTA, INGREZZA, FARXIGA.
Industry payments across MA — which companies pay providers there.
